Vimarsana
Biggest News Aggregation in the World

Page 13 - Pierer Mobility News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pierer Mobility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pierer Mobility Today - Breaking & Trending Today

21st Austria weekly - Strabag, Pierer Mobility (09/01/2023) - Vimarsana News

21st Austria weekly - Strabag, Pierer Mobility (09/01/2023)

21st Austria weekly - Strabag Pierer Mobility 09/01/2023 [pic1]Strabag: Klemens Haselsteiner is the new Chief Executive Officer of construction group Strabag SE. With effect from 1 January 2023 he takes over post Thomas Birtel who has reached maximum age limit after ten years in office. been with Group and held various management positions since 2011. He says: “These are challenging times we living in. The

EQS-Adhoc: PIERER Mobility AG: Another record year in 2022 and positive outlook for 2023 Seite 1 - Vimarsana News

EQS-Adhoc: PIERER Mobility AG: Another record year in 2022 and positive outlook for 2023 Seite 1

09.01.2023 - EQS-Ad-hoc: PIERER Mobility AG / Key word(s): Miscellaneous/Forecast PIERER Mobility AG: Another record year in 2022 and positive outlook for 2023 09-Jan-2023 / 18:24 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the ... Seite 1

21st Austria weekly - Remembering 2022 (31/12/2022) - Vimarsana News

21st Austria weekly - Remembering 2022 (31/12/2022)

21st Austria weekly - Remembering 2022 31/12/2022 [pic1]The last week of the year brought a slightly weaker ATX TR. News came from Erste Group Marinomed Semperit Pierer Mobility S Immo Kontron Immofinanz Valneva Vienna

21st Austria weekly - Valneva, Vienna Stock Exchange (30/12/2022) - Vimarsana News

21st Austria weekly - Valneva, Vienna Stock Exchange (30/12/2022)

21st Austria weekly - Valneva Vienna Stock Exchange 30/12/2022 [pic1]Valneva: an Austrian/French specialty vaccine company reported further heterologous booster data from exploratory small clinical study for its inactivated COVID-19 vaccine VLA2001. The show that a dose of VLA2001 was well tolerated in previously BNT162b2 Pfizer/BioNTech- or mRNA 1273 Moderna-vaccinated participants confirming the favorable safety profile seen across all studies – including homologous settings. However this study additional elicited only marginally increased neutralizing antibody response. Com...

21st Austria weekly - Marinomed, Semperit, Pierer Mobility (27/12/2022) - Vimarsana News

21st Austria weekly - Marinomed, Semperit, Pierer Mobility (27/12/2022)

21st Austria weekly - Marinomed Semperit Pierer Mobility 27/12/2022 [pic1]Marinomed Biotech: Marinomed Biotech AG listed on the Vienna Stock Exchange VSE:MARI announced that United States Patent and Trademark Office has granted patent US11510859 covering Marinosolv